Not logged in.png)
Share.png)
SaveShare Save A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis
Pedersen, Kim; Angelini, Pier-Davide; Laos, Sirle; Bach-Faig, Alba; Cunningham, Matthew P.; Ferrer-Ramon, Cristina; Luque-Garcia, Antonio; Garcia-Castillo, Jesus; Lluis Parra-Palau, Josep; Scaltriti, Maurizio; Ramon y Cajal, Santiago; Baselga, Jose; Arribas, Joaquin Share Save Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaMondello, Patrizia; Tadros, Saber; Teater, Matt; Fontan, Lorena; Chang, Aaron Y.; Jain, Neeraj; Yang, Haopeng; Singh, Shailbala; Ying, Hsia-Yuan; Chu, Chi-Shuen; Ma, Man Chun John; Toska, Eneda; Alig, Stefan; Durant, Matthew; de Stanchina, Elisa; Ghosh, Sreejoyee; Mottok, Anja; Nastoupil, Loretta; Neelapu, Sattva S.; Weigert, Oliver; Inghirami, Giorgio; Baselga, Jose; Younes, Anas; Yee, Cassian; Dogan, Ahmet; Scheinberg, David A.; Roeder, Robert G.; Melnick, Ari M.; Green, Michael R. Share Save The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO studyDi Cosimo, Serena; Triulzi, Tiziana; Pizzamiglio, Sara; De Cecco, Loris; de Azambuja, Evandro; Fumagalli, Debora; Putzai, Lajos; Harbeck, Nadia; Izquierdo, Miguel; de la Pena, Lorena; Daidone, Maria Grazia; Huober, Jens; Gori, Stefania; Cinieri, Saverio; Torri, Valter; Baselga, Jose; Piccart, Martine; de Braud, Filippo G.; Apolone, Giovanni; Verderio, Paolo; Tagliabue, Elda Share Save Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab (vol 28, pg 761, 2017)Swain, S. M.; Schneeweiss, A.; Gianni, L.; Gao, J. J.; Stein, A.; Waldron-Lynch, M.; Heeson, S.; Beattie, M. S.; Yoo, B.; Cortes, J.; Baselga, J. Share Save Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO TrialDi Cosimo, Serena; Appierto, Valentina; Pizzamiglio, Sara; Tiberio, Paola; Iorio, Marilena, V; Hilbers, Florentine; de Azambujas, Evandro; de la Pena, Lorena; Izquierdo, Miguel; Huober, Jens; Baselga, Jose; Piccart, Martine; de Braud, Filippo G.; Apolone, Giovanni; Verderio, Paolo; Daidone, Maria Grazia Share Save Gene expression analysis of paired baseline (BL) and on-treatment tumor samples from FAIRLANE, a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) plus paclitaxel (PAC) in early triple-negative breast cancer (eTNBC)Shi, Zhen; Isakoff, Steven J.; Saura, Cristina; Nuciforo, Paolo; Calvo, Isabel; Andersen, Jay; Passos Coelho, Jose Luis; Gil Gil, Miguel; Bermejo, Begona; Patt, Debra A.; Ciruelos, Eva; Wongchenko, Matthew J.; Singel, Stina M.; Xu, Na; de la Pena, Lorena; Baselga, Jose; Gendreau, Steven; Oliveira, Mafalda Share Save A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene AlterationsVoss, Martin H.; Hierro, Cinta; Heist, Rebecca S.; Cleary, James M.; Meric-Bernstam, Funda; Tabernero, Josep; Janku, Filip; Gandhi, Leena; Iafrate, A. John; Borger, Darrell R.; Ishii, Nobuya; Hu, Youyou; Kirpicheva, Yulia; Nicolas-Metral, Valerie; Pokorska-Bocci, Anna; Chessex, Anne Vaslin; Zanna, Claudio; Flaherty, Keith T.; Baselga, Jose Share Save HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2 (vol 23, pg 4323, 2017)Hanker, Ariella B.; Garrett, Joan T.; Estrada, Monica Valeria; Moore, Preston D.; Ericsson, Paula Gonzalez; Koch, James P.; Langley, Emma; Singh, Sharat; Kim, Phillip S.; Frampton, Garrett M.; Sanford, Eric; Owens, Philip; Becker, Jennifer; Groseclose, M. Reid; Castellino, Stephen; Joensuu, Heikki; Huober, Jens; Brase, Jan C.; Majjaj, Samira; Brohee, Sylvain; Venet, David; Brown, David; Baselga, Jose; Piccart, Martine; Sotiriou, Christos; Arteaga, Carlos L. Share Save Share Save Dose justification for DS-8201a, a HER2-targeted antibody-drug conjugate, for HER2-positive breast cancer: Observed clinical data and exposure-response analysesTamura, K.; Modi, S.; Tsurutani, J.; Takahashi, S.; Krop, I. E.; Iwata, H.; Wada, R.; Yin, O.; Garimella, T.; Sugihara, M.; Zhang, L.; Lee, C.; Yver, A.; Baselga, J. Share Save A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutationCastroviejo-Bermejo, Marta; Cruz, Cristina; Llop-Guevara, Alba; Gutierrez-Enriquez, Sara; Ducy, Mandy; Hussein Ibrahim, Yasir; Gris-Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzman, Marta; Rodriguez, Olga; Grueso, Judit; Bonache, Sandra; Moles-Fernandez, Alejandro; Villacampa, Guillermo; Viaplana, Cristina; Gomez, Patricia; Vidal, Marc; Peg, Vicente; Serres-Creixams, Xavier; Dellaire, Graham; Simard, Jacques; Nuciforo, Paolo; Rubio, Isabel T.; Dientsmann, Rodrigo; Barrett, J. Carl; Caldas, Carlos; Baselga, Jose; Saura, Cristina; Cortes, Javier; Deas, Olivier; Jonkers, Jos; Masson, Jean-Yves; Cairo, Stefano; Judde, Jean-Gabriel; O'Connor, Mark J.; Diez, Orland; Balmana, Judith; Serra, Violeta Share Save Share Save Development of plasma cell-free DNA (cfDNA) assays for early cancer detection: first insights from the Circulating Cell-Free Genome Atlas Study (CCGA)Aravanis, Alexander A.; Oxnard, Geoffrey R.; Maddala, Tara; Hubbell, Earl; Venn, Oliver; Jamshidi, Arash; Shen, Ling; Amini, Hamed; Beausang, John A.; Betts, Craig; Civello, Daniel; Davydov, Konstantin; Fazullina, Saniya; Filippova, Darya; Gnerre, Sante; Gross, Samuel; Hou, Chenlu; Jiang, Roger; Jung, Byoungsok; Kurtzman, Kathryn; Melton, Collin; Nautiyal, Shivani; Newman, Jonathan; Newman, Joshua; Nicolaou, Cosmos; Rava, Richard; Sakarya, Onur; Satya, Ravi Vijaya; Shojaee, Seyedmehdi; Steffen, Kristan; Valouev, Anton; Xu, Hui; Yue, Jeanne; Zhang, Nan; Baselga, Jose; Lapham, Rosanna; Davis, Daron G.; Smith, David; Richards, Donald; Seiden, Michael V.; Swanton, Charles; Yeatman, Timothy J.; Tibshirani, Robert; Curtis, Christina; Plevritis, Sylvia K.; Williams, Richard; Klein, Eric; Hartman, Anne-Renee; Liu, Minetta C. Share Save Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer PatientsLambertini, Matteo; Campbell, Christine; Bines, Jose; Korde, Larissa A.; Izquierdo, Miguel; Fumagalli, Debora; Del Mastro, Lucia; Ignatiadis, Michail; Pritchard, Kathleen; Wolff, Antonio C.; Jackisch, Christian; Lang, Istvan; Untch, Michael; Smith, Ian; Boyle, Frances; Xu, Binghe; Barrios, Carlos H.; Baselga, Jose; Moreno-Aspitia, Alvaro; Piccart, Martine; Gelber, Richard D.; de Azambuja, Evandro Share Save Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancervon Minckwitz, Gunter; Procter, Marion; de Azambuja, Evandro; Zardavas, Dimitrios; Benyunes, Mark; Viale, Giuseppe; Suter, Thomas; Arahmani, Amal; Rouchet, Nathalie; Clark, Emma; Knott, Adam; Lang, Istvan; Levy, Christelle; Yardley, Denise A.; Bines, Jose; Gelber, Richard D.; Piccart, Martine; Baselga, Jose Share Save Patient-derived tumor xenografts (PDXs) recapitulate the antitumor activity of novel therapies in metastatic breast cancer (MBC) patients (pts)Oliveira, Mafalda; Pascual, Javier; Cruz, Cristina; Gris, Alberto; Palafox, Marta; Llop, Alba; Castroviejo, Marta; Viaplana, Cristina; Ibrahim, Yasir H.; Arribas, Joaquin; Cortes, Javier; Baselga, Jose; Rodon, Jordi; Balmana, Judith; Dienstmann, Rodrigo; Saura, Cristina; Serra, Violeta Share Save Oncologist use and perception of large panel next generation tumor sequencingSchram, Alison M.; Reales, Dalicia; Galle, Jesse; Cambria, Roy; Durany, Robert; Feldman, Darren; Sherman, Eric; Rosenberg, Jonathan; D'Andrea, Gabriella; Baxi, Shrujal; Janjigian, Yelena; Tap, William; Dickler, Maura; Baselga, Jose; Taylor, Barry; Chakravarty, Debyani; Gao, Jianjiong; Schultz, Nikolaus D.; Solit, David B.; Berger, Michael F.; Hyman, David M. Share Save Tumor-specific PI3K inhibition via nanoparticle targeted delivery in head and neck squamous cell carcinomaMizrachi, Aviram; Shamay, Yosi; Shah, Janki; Brook, Samuel I.; Soong, Joanne; Rajasekhar, Vinagolu K.; Humm, John L.; Powell, Simon N.; Baselga, Jose; Heller, Daniel A.; Haimovitz-Friedman, Adriana; Scaltriti, Maurizio Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
